271 related articles for article (PubMed ID: 3882744)
21. Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.
Guth BE; Twiddy EM; Trabulsi LR; Holmes RK
Infect Immun; 1986 Nov; 54(2):529-36. PubMed ID: 2429930
[TBL] [Abstract][Full Text] [Related]
22. Escherichia coli heat-labile enterotoxin: comparison of antitoxin assays and serum antitoxin levels.
Wachsmuth IK; Wells JG; Ryder RW
Infect Immun; 1977 Nov; 18(2):348-51. PubMed ID: 336543
[TBL] [Abstract][Full Text] [Related]
23. Rapid and differential detection of two analogous enterotoxins of Vibrio cholerae and enterotoxigenic Escherichia coli by a modified enzyme-linked immunosorbent assay.
Koike N; Okada K; Yabushita Y; Zhang D; Yamamoto K; Miwatani T; Honda T
FEMS Immunol Med Microbiol; 1997 Jan; 17(1):21-5. PubMed ID: 9012440
[TBL] [Abstract][Full Text] [Related]
24. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.
Robb M; Nichols JC; Whoriskey SK; Murphy JR
Infect Immun; 1982 Oct; 38(1):267-72. PubMed ID: 6183210
[TBL] [Abstract][Full Text] [Related]
25. Immunogenic and antigenic characteristics of Salmonella heat-labile enterotoxin.
Kaura YK; Sharma VK
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):386-404. PubMed ID: 3136609
[TBL] [Abstract][Full Text] [Related]
26. Antigenic determinants of the cholera/coli family of enterotoxins.
Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
Rev Infect Dis; 1987; 9 Suppl 5():S490-502. PubMed ID: 2446368
[TBL] [Abstract][Full Text] [Related]
27. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
28. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
[TBL] [Abstract][Full Text] [Related]
29. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
Bowman CC; Clements JD
Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
[TBL] [Abstract][Full Text] [Related]
30. Development of a vaccine against experimental cholera and Escherichia coli diarrheal disease.
Rappaport RS; Bonde G
Infect Immun; 1981 May; 32(2):534-41. PubMed ID: 7019073
[TBL] [Abstract][Full Text] [Related]
31. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.
Klipstein FA; Engert RF
Infect Immun; 1985 Jun; 48(3):629-33. PubMed ID: 3922890
[TBL] [Abstract][Full Text] [Related]
32. Epitopes of the cholera family of enterotoxins.
Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
Rev Infect Dis; 1987; 9(3):544-61. PubMed ID: 2440089
[TBL] [Abstract][Full Text] [Related]
33. Rapid visual detection of Escherichia coli and Vibrio cholerae Heat-labile enterotoxins by nitrocellulose enzyme-linked immunosorbent assay.
Beutin L; Bode L; Richter T; Peltre G; Stephan R
J Clin Microbiol; 1984 Mar; 19(3):371-5. PubMed ID: 6371043
[TBL] [Abstract][Full Text] [Related]
34. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
Tamura SI; Kurata T
Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
[TBL] [Abstract][Full Text] [Related]
35. Differential interaction of Escherichia coli heat-labile toxin and cholera toxin with pig intestinal brush border glycoproteins depending on their ABH and related blood group antigenic determinants.
Balanzino LE; Barra JL; Monferran CG; Cumar FA
Infect Immun; 1994 Apr; 62(4):1460-4. PubMed ID: 7510669
[TBL] [Abstract][Full Text] [Related]
36. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
Klipstein FA; Engert RF
Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
[TBL] [Abstract][Full Text] [Related]
37. [Method for the detection and determination of heat-labile Escherichia coli enterotoxin by an immunoenzyme technic on a new polystyrene support adapted for a test kit].
Germani Y; Begaud E; Dassy B; Legonidec G; Guesdon JL
Ann Microbiol (Paris); 1984; 135B(3):297-310. PubMed ID: 6398008
[TBL] [Abstract][Full Text] [Related]
38. Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin.
Brandwein H; Deutsch A; Thompson M; Giannella R
Infect Immun; 1985 Jan; 47(1):242-6. PubMed ID: 3880723
[TBL] [Abstract][Full Text] [Related]
39. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
[TBL] [Abstract][Full Text] [Related]
40. Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.
Holmgren J; Svennerholm AM; Gothefors L; Jertborn M; Stoll B
Infect Immun; 1988 Jan; 56(1):230-3. PubMed ID: 3275584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
